As we all know that albumin is a negative inflammatory phase reactant. In severe inflammation, the level of albumin goes down. In one of our reviews, we found that hypoalbuminemia is occurring in greater than 60% of the COVID-19 participants and the risk ratio of increase is greater in severe as compared to non-severe patients 60% prevalence. But a published report from Lancet Gastroenterology and hepatology is reporting a 6% prevalence of hypoalbuminemia Lancet study.

What are the prevalence of hypoalbuminemia in your respective healthcare settings among COVID-19 patients? Is it a routine that you encounter? Can we take this hypoalbuminemia as a surrogate marker for severity of COVID-19?

Declaration of interest: I am a part of the author of the first link. The question is for scientific clarification in the forum.

Your Answer

By clicking “Post Your Answer”, you agree to our terms of service, privacy policy and cookie policy

Browse other questions tagged or ask your own question.